During the past decade, Catalan Institute of Oncology conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Catalan Institute of Oncology" #1 sponsor was "Institut Català d'Oncologia" with 3 trials, followed by "Affimed GmbH" with 1 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Ayala Pharmaceuticals, Inc," with 1 trials sponsored and "Basilea Pharmaceutica" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Catalan Institute of Oncology" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator, "Carl Zeiss Meditec AG" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Catalan Institute of Oncology" are "Breast Cancer" (2 trials), "Adenoid Cystic Carcinoma" (1 trials), "Advanced Solid Tumors or Lymphomas" (1 trials), "Brain Metastases From Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Childhood Teratoma" (1 trials). Many other conditions were trialed in "Catalan Institute of Oncology" in a lesser frequency.

Most popular intervention types in "Catalan Institute of Oncology" are "Drug" (11 trials), "Behavioral" (3 trials), "Other" (3 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "AFM13" (1 trials), "AL102" (1 trials), "Atezolizumab" (1 trials), "Best Standard of Care" (1 trials) and "CA-170" (1 trials). Other intervention names were less common.

The vast majority of trials in "Catalan Institute of Oncology" are 13 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Catalan Institute of Oncology". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Catalan Institute of Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Catalan Institute of Oncology, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".